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Abstract (236 words) 
We examined the association between metabolically healthy overweight/obesity and the risk of 
sudden cardiac death in middle-aged men. This prospective study was based on a population 
sample of 2185 men aged 42-60 years in the Kuopio Ischemic Heart Disease cohort study. 
Participants were divided into 4 groups based on body mass index and metabolic health status. 
Metabolically healthy overweight/obesity was defined as a body mass index ≥25 kg/m2 without 
metabolic abnormalities, and metabolically unhealthy normal weight was defined as body mass 
index <25 kg/m2 with ≥1 metabolic abnormalities. During a median follow-up of 26 years 
(interquartile ranges: 18.7-28.1 years), 240 sudden cardiac deaths occurred. Compared with 
metabolically healthy normal weight men, metabolically unhealthy overweight/obese men had 
a greater risk of sudden cardiac death (hazard ratio [HR] 1.99, 95% Confidence Interval [CI]: 
1.03-3.85) after adjusting for potential confounders. However, metabolically healthy 
overweight/obese men were not at increased risk of sudden cardiac death (HR 0.95, 95% CI, 
0.40-2.24) as compared with their metabolically healthy normal weight counterparts after 
adjusting for age, smoking, low-density lipoprotein cholesterol, high sensitivity C-reactive 
protein, insulin, history of myocardial infarction, and directly measured peak oxygen uptake. 
Our findings indicate that metabolically healthy normal weight men and metabolically healthy 
overweight/obese men were at comparable risk of sudden cardiac death over a 26 year follow-
up period, suggesting that a baseline body mass index ≥25 kg/m2 per se doesn’t adversely 
impact the risk of sudden cardiac death.  
 
Key words: sudden cardiac death, obesity, metabolically healthy obesity.  
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Abbreviation 
BMI   body mass index  
CHD   coronary heart disease  
CI   Confidence Interval 
CVD   cardiovascular disease     
ECG   electrocardiographic 
HR   hazard ratio 
KIHD               Kuopio Ischaemic Heart Disease Risk Factor Study 
MHNW  metabolically healthy normal weight 
MHOO   metabolically healthy overweight-obese 
MHO   metabolically healthy obese 
MUNW  metabolically unhealthy normal weight  
MUOO   metabolically unhealthy overweight-obese    
SCD   sudden cardiac death     
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Introduction 
Although metabolically healthy obese (MHO) individuals appear to be at higher risk of 
coronary heart disease (CHD), cerebrovascular disease, and heart failure than their 
metabolically healthy normal weight counterparts,1 other studies have reported no association 
between MHO and cardiovascular events.2,3 Furthermore, it remains unclear whether 
differences in body habitus and metabolic health profiles extend to cardiac arrest as a 
predictable cardiovascular outcome in the general population. Sudden cardiac death (SCD) is 
a global public health concern, accounting for up to 50% of all cardiovascular deaths. While 
obesity has been associated with a greater risk of SCD, the impact of overweight/obesity on 
the incidence of SCD remains unclear due to inherent confounding variables.4,5 To further 
clarify these potential risk modulators, we examined the association between metabolically 
healthy overweight/obese middle-aged men and the risk of SCD over an extended follow-up.  
Methods  
 This prospective investigation included participants in the Kuopio Ischaemic Heart 
Disease Risk Factor Study (KIHD), which is a prospective population-based long-term analysis 
designed to evaluate risk factors for cardiovascular disease (CVD) and related outcomes in a 
randomly selected sample of men from eastern Finland. Of the original cohort of 3433 men 
who resided in the town of Kuopio or its surrounding rural communities, 198 were excluded 
for varied reasons (eg, serious disease, moved from the area). At baseline, examinations were 
conducted on 2682 men (82.9% of the eligible population) between March 1984 and December 
1989. Participants whose blood markers and anthropometric variables were initially assessed 
were included in the present analysis (n=2,185, aged 42-60 years). The KIHD study was 
approved by the Research Ethics Committee of the University of Eastern Finland and all study 
participants provided written informed consent. 
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Body mass index (BMI) was calculated as weight (kg) divided by height squared (m2). 
Our cohort did not include any participants who were underweight (BMI <18.5 kg/m2). Resting 
blood pressure was measured using a sphygmomanometer and was expressed as the mean value 
from 6 different measurements (3 while supine, 1 while standing, and 2 while sitting). Blood 
samples were collected in the morning following a 12 hour overnight fast and analyzed 
according to standard protocols. Laboratory methods and other assessments are described 
elsewhere.6 Peak oxygen uptake as an index of cardiorespiratory fitness was directly measured 
using a computerized metabolic measurement system during an electrically braked progressive 
cycle ergometer exercise test to volitional fatigue.  
Our study population was divided into 4 groups based on cross-classification of BMI 
and metabolic health status: metabolically healthy normal weight (MHNW); metabolically 
unhealthy normal weight (MUNW); metabolically healthy overweight-obese (MHOO); and, 
metabolically unhealthy overweight-obese (MUOO). We used a hybrid MHO definition with 
a modified BMI (original BMI cut-off was ≥30 kg/m2) as previously suggested.7 Being 
MHOO was defined as a BMI ≥25 kg/m2 with “0” or no metabolic abnormalities or risk 
factors as signified by the following: systolic blood pressure ≥130 mmHg or diastolic blood 
pressure ≥85 mm Hg or antihypertensive drug treatment; high-density lipoprotein cholesterol 
<40 mg/dL (1.0 mmol/L); serum triglycerides ≥150 mg/dL (1.7 mmol/L) or treatment for 
hypertriglyceridemia; and fasting blood glucose ≥100 mg/dL (5.6 mmol/L) or treatment 
with hypoglycemic agents. We excluded waist circumference from the definition of MHO, 
since most participants met the criteria for a high waist circumference.7  
 SCD was defined as a fatal event that occurred within 1 h after the onset of symptoms 
or within 24 h when autopsy data did not reveal a non-cardiac cause of SCD or after a fatal 
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cardiac arrest following successful resuscitation from ventricular tachycardia and/or 
ventricular fibrillation. Diagnostic classification of events was based on symptoms, 
electrocardiographic (ECG) findings, cardiac enzyme elevations, autopsy findings (80% of the 
SCDs) and history of CHD combined with relevant clinical and ECG findings. Data on SCDs 
were derived from interviews with family members, hospital records, death certificates, 
autopsy reports and medico-legal documents. A detailed definition of SCD has been previously 
described.6  
We calculated the hazard ratio (HR) and 95% confidence intervals (CI) from 
multivariable Cox proportional hazard model with adjustment for confounding variables to 
determine the relations of body phenotypes (ie, normal weight, overweight-obese) to the risk 
of SCD. For the multivariable analysis, potential confounding variables (ie, covariates) were 
selected as variables with statistically significant differences among groups as shown Table 1. 
Statistical significance was set at P<.05 and analyses were conducted using SPSS version 21.0 
(SPSS, Armonk, NY).   
Results 
 Table 1 shows baseline characteristics of the study participants grouped by metabolic 
health status and body habitus. We found that 193 of the 2,185 participants (8.8%) were 
classified as MHOO. There were significant differences in age, BMI, smoking, history of 
myocardial infarction, prevalence of diabetes and hypertension, resting systolic/diastolic blood 
pressures, lipid/lipoprotein profiles, glucose, insulin, high sensitivity C-reactive protein, and 
peak oxygen uptake among the 4 groups (P<.05).  
During a median follow-up of 26 years (interquartile ranges: 18.7-28.1 years), 240 
(11%) SCDs occurred. Compared with MHNW men, those who were classified as MHOO 
were not at increased risk of SCD (hazard ratio [HR] 0.95, 95% Confidence Interval [CI]: 0.40-
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2.24) after adjusting for age, smoking, low-density lipoprotein cholesterol, high sensitivity C-
reactive protein, insulin, history of myocardial infarction, and peak oxygen uptake. However, 
MUOO men had a greater risk of SCD (HR 1.99, 95% CI, 1.03-3.85) as compared with their 
MHNW counterparts (Table 2). The Kaplan-Meier survival analysis showed that the survival 
rate of SCD in MHOO was similar to that of MHNW cohort (Figure 1).   
Discussion 
 Although obesity is associated with an increased risk of SCD,3 and selected risk factors 
may predispose obese men to an increased risk of SCD, it appears that these and other risk 
factors operate differently in patients with and without preexisting ischemic heart disease.5 
Thus, the impact of obesity on incident SCD remains unclear due to potential confounding 
variables and/or substantial unexplained variance. Over a 26-year follow-up, we found that 
men who were MHOO were not at greater risk of SCD as compared with their MHNW 
counterparts. Our results are consistent with previous reports2,3,8 and further extend the impact 
of MHOO on SCD risk as counterintuitively related to ‘healthy or unhealthy overweight-
obese’.9  
To our knowledge, this is the first long-term study to report that MHOO men were not 
at elevated risk for SCD, as compared with their metabolically healthy, normal weight peers. 
However, additional studies needed to confirm these results. In contrast, the largest prospective 
study to date, over a 5.4 year follow-up, found that MHO persons were at increased risk of 
CHD, cerebrovascular disease, and heart failure, but not peripheral vascular disease, as 
compared with MHNW individuals.1 Interestingly, a sub-group analysis with a relatively long-
term follow-up (>10 years) reported that subjects with MHO were at increased risk of all-cause 
mortality and CVD events.2 Another investigation using the strictest definition for metabolic 
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health, that is, no metabolic abnormalities, found no association between MHO and CVD 
events.3 However, the analysis had limited statistical power.  
We believe that varied definitions of metabolic health, body habitus (eg, obesity vs 
overweight-obesity), follow-up durations and gender differences may, at least in part, be 
responsible for the conflicting data in the literature. Furthermore, another reason for these 
conflicting results may be the inability to account for physical activity/cardiorespiratory fitness 
as important potential confounding variables.9-11 It is interesting to note that those studies that 
adjusted for cardiorespiratory fitness or physical activity did not find increased risk of CVD 
mortality in MHO,12,13 which is compatible with the present findings. In our 26 year follow-up 
study, after adjusting for potential confounders, including cardiorespiratory fitness, MHOO 
men were not an increased risk of SCD as compared with MHNW men.  
In reference to the association between body habitus, cardiometabolic risk factors and 
the risk of SCD, our results showed that MUNW men were not at a significantly greater risk 
for incident SCD than their MHNW counterparts. However, the risk for incident SCD in 
MUNW men appears to be at greater than that of MHNW men. The present findings are 
consistent with previous studies that reported increased risk of mortality in MUNW as 
compared with MHNW.14 Accordingly, strategies of prevention/treatment should consider the 
individual’s metabolic health status as an important confounding variable in overweight/obese 
individuals and in normal weight individuals. However, additional studies are needed to further 
clarify the relation between metabolically unhealthy non-obese individuals and the risk of SCD.  
We acknowledge several methodologic limitations. Because our study population 
included only men, we were unable to determine whether this association extends to women. 
Although we adjusted for numerous potential confounders, other variables that we did not 
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assess may have influenced these associations. Unfortunately, our database did not include 
selected ECG variables, specifically QRS duration, QT intervals, and the Tpeak-Tend interval, 
as well as heart rate variability and left ventricular ejection fraction, all of which may be related 
to the incidence of SCD. Inclusion of these parameters in future studies would provide 
additional mechanistic insights relative to the associated risk modulators. In addition, our total 
SCDs (n=240) and study cohorts were relatively small, especially MHNW (n=232) and MHOO 
(n=193), and we grouped overweight and obese men together into the MHOO subset. It remains 
unclear whether similar results would have been obtained using only obese individuals (BMI 
≥30 kg/m2) to characterize the MHO phenotype,15 rather than combining overweight and obese 
participants into one cohort. Finally, we categorized our 4 study groups based on BMI and 
cardiometabolic risk factors only at baseline, and acknowledge that body habitus and/or 
metabolic profiles may have changed over time. Despite these limitations, strengths of this 
study include the assessment of outcomes over a long-term follow-up (a median of 26 years; 
interquartile ranges: 18.7-28.1 years), and that cardiorespiratory fitness, a strong potential 
confounder which is often either estimated or unaccounted for in major MHO related 
studies,10,11 was directly measured as peak oxygen uptake.  
Conclusion 
Our results demonstrate that compared with MHNW men, MUOO men had greater risk 
of SCD, but MHOO men were not at increased risk of SCD after adjusting for potential 
confounders, including cardiorespiratory fitness, over a 26 year follow-up.  
Conflict of Interest 
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Figure Legends.  
Figure 1. Kaplan-Meier survival curves for sudden cardiac death among the metabolically 
healthy and unhealthy normal weight and overweight-obese men. Log-rank test (Mantel-
Cox) for survival difference between the various curves (MHNW vs. MUNW, P=.039; 
MHNW vs. MHOO, P=.601; MHNW vs. MUOO, P<.001; MUNW vs. MHOO, P=.165; 
MUNW vs. MUOO, P=.020; MHOO vs. MUOO, P=.002). 
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Table 1. Baseline characteristics of the participants according to metabolic health status and body habitus (n=2185). 
Variables 
MHNW 
(n=232) 
MUNW 
(n=439) 
MHOO 
(n=193) 
MUOO 
(n=1321) 
P-value 
Age (years) 52.3±5.8 52.4±5.0 52.5±5.1 53.2±4.9 .003 
Body mass index (kg/m
2
) 23.0±1.4 23.4±1.3 27.2±2.2 28.7±2.9 <.001 
Smokers (%) 40.5 38.3 36.3 26.6 <.001 
Family history of coronary heart disease (%) 46.6 52.2 46.6 50.3 .687 
History of myocardial infarction (%) 6.5 5.0 7.8 8.3 .050 
Diabetes (%) 0.0 3.4 0.0 8.1 <.001 
Hypertension (%) 0.0 24.6 0.0 25.7 <.001 
Systolic blood pressure (mmHg) 117.1±7.4 135.0±14.5 117.5±7.6 139.5±16.4 <.001 
Diastolic blood pressure (mmHg) 76.7±4.9 89.0±8.6 77.9±4.8 92.8±9.8 <.001 
High-density lipoprotein cholesterol (mmol/L) 1.47±0.3 1.34±0.3 1.34±0.2 1.23±0.3 <.001 
Low-density lipoprotein cholesterol (mmol/L) 3.86±0.9 4.01±1.0 4.02±1.0 4.06±1.0 .031 
Triglycerides (mmol/L) 0.86±0.3 1.14±0.7 0.99±0.3 1.45±0.9 <.001 
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Glucose (mmol/L) 4.41±0.4 4.56±0.7 4.49±0.4 4.93±1.3 <.001 
Insulin (mU/l) 7.42±2.8 8.71±3.2 10.37±5.6 13.53±8.0 .001 
C-reactive protein (mg/L) 1.81±4.6 1.90±3.0 2.25±3.9 2.54±3.3 .001 
Peak oxygen uptake (ml/kg/min) 34.8±8.9 32.9±8.0 31.4±7.2 28.3±7.3 <.001 
Data are mean (standard deviations) or percentage. MHNW: metabolically healthy normal weight; MUNW: metabolically unhealthy normal 
weight; MHOO: metabolically healthy overweight-obese; MUOO: metabolically unhealthy overweight-obese    
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Table 2. Multivariate hazard ratios (95% CI) of sudden cardiac death across metabolic health status and body habitus. 
Variables 
Multivariate 
Hazard ratios (95% CI) 
 
Sudden cardiac death  
 
Metabolically healthy normal weight 1 (ref) 
 
Metabolically unhealthy normal weight 1.91 (0.95-3.82) 
 
Metabolically healthy overweight-obese 0.95 (0.40-2.24) 
 
Metabolically unhealthy overweight-obese 1.99 (1.03-3.85) 
 
   
Adjusted for age, smoking, low-density lipoprotein cholesterol, high sensitivity C-reactive protein, insulin, history of myocardial infarction, and 
peak oxygen uptake. 
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